Reading is a quiet collaboration between reader and page—a sustained immersion where typography either supports the experience or subtly fractures it. It’s surprising how quickly a typeface can tip that balance: a too-sharp italic, a… Read More »Where Type Shapes the Reading Experience: Ensaio from DSType Foundry
Debbie Millman’s ongoing project “What Matters,” an effort to understand the interior life of artists, designers, and creative thinkers, is now in its third year. Each respondent is invited to answer ten identical questions and… Read More »What Matters to Rose Albanese
1664 joins forces with French artist Camille Walala.
Platform will be used in modifications of all 67 software packages provided to medical and governmental industry customers by end of fiscal year 2026 TOKYO, Feb. 17, 2026 /PRNewswire/ — Fujitsu Limited today announced… Read More »Fujitsu automates entire software development lifecycle with new AI-Driven Software Development Platform
The WBD-Netflix Transaction Delivers Incredible Value and Certainty to WBD Stockholders with Clear Path to Timely Regulatory Approval Netflix is the Superior Deal and the Only Deal Before WBD Stockholders Together WBD and Netflix… Read More »WBD Files Definitive Proxy Statement and Schedules Special Meeting for March 20, 2026, to Approve the WBD-Netflix Transaction
Amai Proteins announces a major milestone for sweelin® in the U.S. market. The U.S. FDA has completed its review of the GRAS (Generally Recognized as Safe) notice for sweelin® and confirmed it has no… Read More »sweelin® is now FDA GRAS Approved, Clearing the Path for Accelerated U.S. Commercialization